Increased endothelial cell retraction and tumor cell invasion by soluble factors derived from pancreatic cancer cells. 1997

S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan.

BACKGROUND Tumor cells induce endothelial cell retraction before invasion. In pancreatic cancer cells, the factors affecting endothelial cell retraction are not well-understood. METHODS The activities of the endothelial cell retraction in conditioned media (CM) derived from three human pancreatic cancer cell lines, PSN-1, MiaPaca-2, and Capan-1, were measured for the amount of intercellular junctional transport of FITC dextran through an endothelial cell monolayer in a transwell cell culture system. RESULTS The CM derived from the three pancreatic cancer cells induced endothelial cell retraction. The endothelial cell retraction activity in the CM from PSN-1 cells was significantly higher than those from MiaPaca-2 and Capan-1 cells. The CM from PSN-1 cells enhanced both the adhesion and the invasion of MiaPaca-2 and Capan-1 cells. The factors with endothelial cell retraction activity in the CM from PSN-1 cells were characterized as heat-stable, trypsin-sensitive glycoproteins ranging from 10,000 to 50,000 in molecular weight, and were found both in heparin-bound and unbound fractions. CONCLUSIONS PSN-1 cells produced and secreted at least two factors inducing the endothelial cell retraction. The factors could play an important role in the establishment of invasion and metastasis of PSN-1 cells.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D005591 Chemical Fractionation Separation of a mixture in successive stages, each stage removing from the mixture some proportion of one of the substances, for example by differential solubility in water-solvent mixtures. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Fractionation, Chemical,Chemical Fractionations,Fractionations, Chemical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D016650 Fluorescein-5-isothiocyanate Fluorescent probe capable of being conjugated to tissue and proteins. It is used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques. FITC,5-Isothiocyanatofluorescein,Fluorescein (5 or 6)-Isothiocyanate,Fluorescein-5-isothiocyanate Hydrochloride,5 Isothiocyanatofluorescein,Fluorescein 5 isothiocyanate,Fluorescein 5 isothiocyanate Hydrochloride,Hydrochloride, Fluorescein-5-isothiocyanate

Related Publications

S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
September 2009, The Journal of surgical research,
S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
January 2018, International journal of clinical and experimental pathology,
S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
January 2018, OncoTargets and therapy,
S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
January 2018, PloS one,
S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
September 2013, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
January 2013, PloS one,
S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
July 1983, Cancer research,
S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
December 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
February 1995, Laboratory investigation; a journal of technical methods and pathology,
S Nakamori, and H Okamoto, and T Kusama, and K Shinkai, and M Mukai, and H Ohigashi, and O Ishikawa, and H Furukawa, and S Imaoka, and H Akedo
January 1994, Cancer research,
Copied contents to your clipboard!